NJ Justices OK Centralizing Abilify Side-Effect Suits
The New Jersey Supreme Court has agreed to give multicounty litigation designation to lawsuits against Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical Inc. over certain side effects relating to the antipsychotic...To view the full article, register now.
Already a subscriber? Click here to view full article